|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
10
|
|
pubmed:dateCreated |
1998-6-29
|
|
pubmed:abstractText |
We retrospectively analysed neuromuscular toxicity associated with paclitaxel 210 mg m(-2) given by 3-h infusion in 247 patients. The severity correlated significantly with total cumulative dose, but could not be predicted by the pretreatment clinical variables or by pharmacokinetic parameters. The toxicity tended to occur in early treatment cycles.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
0007-0920
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
77
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1686-8
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:9635850-Adult,
pubmed-meshheading:9635850-Aged,
pubmed-meshheading:9635850-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:9635850-Arthralgia,
pubmed-meshheading:9635850-Female,
pubmed-meshheading:9635850-Humans,
pubmed-meshheading:9635850-Infusions, Intravenous,
pubmed-meshheading:9635850-Male,
pubmed-meshheading:9635850-Middle Aged,
pubmed-meshheading:9635850-Muscles,
pubmed-meshheading:9635850-Neuromuscular Diseases,
pubmed-meshheading:9635850-Paclitaxel,
pubmed-meshheading:9635850-Peripheral Nervous System Diseases,
pubmed-meshheading:9635850-Retrospective Studies
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Neuromuscular toxicities of paclitaxel 210 mg m(-2) by 3-hour infusion.
|
|
pubmed:affiliation |
Department of Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
